Safety and immunogenicity of SpikoGen®, an Advax-CpG55.2-adjuvanted SARS-CoV-2 spike protein vaccine: a phase 2 randomized placebo-controlled trial in both seropositive and seroneg...

por Tabarsi, Payam, Anjidani, Nassim, Shahpari, Ramin, Mardani, Masoud, Sabzvari, Araz, Yazdani, Babak, Roshanzamir, Khashayar, Bayatani, Behnam, Taheri, Ali, Petrovsky, Nikolai, Li, Lei, Barati, Saghar
Publicado 2022

Evaluating the efficacy and safety of SpikoGen®, an Advax-CpG55.2–adjuvanted severe acute respiratory syndrome coronavirus 2 spike protein vaccine: a phase 3 randomized placebo-con...

por Tabarsi, Payam, Anjidani, Nassim, Shahpari, Ramin, Mardani, Masoud, Sabzvari, Araz, Yazdani, Babak, Kafi, Hamidreza, Fallah, Newsha, Ebrahimi, Ali, Taheri, Ali, Petrovsky, Nikolai, Barati, Saghar
Publicado 2023

Immunogenicity and Safety of SpikoGen, an Adjuvanted Recombinant SARS-CoV-2 Spike Protein, as a Heterologous Third Booster Dose in Kidney Transplant Patients: A Single-arm Clinical...

por Nafar, Mohsen, Mostafaloo, Narges, Firouzan, Ahmad, Poorrezagholi, Fatemeh, Samadian, Fariba, Dalili, Nooshin, Barati, Saghar, Anjidani, Nassim, Kafi, Hamidreza, Shahpari, Ramin, Bayat, Mahdiye, Kianipour, Soha, Samavat, Shiva
Publicado 2022